Somatostatinoma is a rare neuroendocrine tumor (NET) with an incidence of 1 in 40 million individuals and accounts for less than 5% of pancreatic NETs (pNETs). This activity outlines the evaluation and treatment of somatostatinoma and highlights the role of the interprofessional team in managing patients with this condition.

**Objectives:**
- Describe the pathophysiology of somatostatinoma.
- Outline the typical presentation and common exam findings of a patient with somatostatinoma.
- Summarize the typical imaging findings associated with somatostatinoma.
- Explain the importance of care coordination among the interprofessional team to decide management based on prognosis.